Age: 52.0
Sex: F
Vaccine: FLUC3, PPV, VARZOS
Symptoms: Injection site erythema, Injection site pruritus
Clinical narrative: Left upper arm erythema, itching, local reaction; Left upper arm erythema, itching, local reaction; This spontaneous case was retrieved on 21-Dec-2020 from Vaccine Adverse Event Reporting System (VAERS) (reference number: 893952-1), reported by other health professional and concerned a 52-year-old, female patient.  The patient's concurrent conditions included depression, sleep apnea, gastrointestinal ulcer, supraventricular tachycardia (SVT), atrial fibrillation, migraines, kidney stone, hypertension (HTN), obesity, anxiety, anaemia, egg allergy, allergy to animal dander and allergy to iron, gabapentin, Lamictal (lamotrigine), Morphine (morphine hydrochloride), Cipro (ciprofloxacin hydrochloride monohydrate), codeine, Flagyl (metronidazole benzoate) and Prozac (fluoxetine hydrochloride). The patient had gastric bypass. The patient's concomitant medications included ASA (acetylsalicylic acid), Klonopin (clonazepam), Benadryl (diphenhydramine hydrochloride), Cymbalta (duloxetine hydrochloride), Flonase (fluticasone propionate), Levsin (hyoscyamine sulfate), Toradol (ketorolac tromethamine), Singulair (montelukast sodium), Macrobid (nutrofurantoin), Protonix (omeprazole), Phenergan (promethazine), Restoril (chlormezanone), Zanaflex (tizanidine hydrochloride), Trazadone (trazodone hydrochloride) and Diovan (valsartan), all used for an unreported  indication.   On 26-Oct-2020, the patient was vaccinated with Flucelvax Quadrivalent (influenza vaccine, subunit influenza virus vaccine polyvalent; anatomical location: right arm, route of administration, dose and indication: not reported). The batch number reported was 279843.   On the same day, the patient was vaccinated with non-company, co-suspect vaccines: Pneumovax (pneumococcal vaccine polysacch 23v; anatomical location: left arm, batch number: T021485, route of administration, dose and indication: not reported) and Shingrix (varicella zoster vaccine rge (cho); dose reported as one, anatomical location: left arm, batch number: 33T27, route of administration and indication: not reported).   On 30-Oct-2020, four days after receiving Flucelvax Quadrivalent, Pneumovax and Shingrix, the patient experienced local reaction left upper arm erythema, itching. The patient visited physician's office; however, further details were not provided.  The outcome of events was unknown.   The reporter did not provide causality assessment.  The case was assessed as non-serious.  Company comment: A 52-year-old, female patient developed erythema and pruritus (both reported as left upper arm erythema, itching, local reaction) four days after vaccination with the suspect product, Flucelvax Quadrivalent and non-company, co-suspect vaccines Pneumovax and Shingrix. Flucelvax Quadrivalent was administered in the right arm, whereas Pneumovax and Shingrix have been administered in the left arm. Due to biological implausibility, causality of the suspect product is assessed as not related.; Sender's Comments: A 52-year-old, female patient developed erythema and pruritus (both reported as left upper arm erythema, itching, local reaction) four days after vaccination with the suspect product, Flucelvax Quadrivalent and non-company, co-suspect vaccines Pneumovax and Shingrix. Flucelvax Quadrivalent was administered in the right arm, whereas Pneumovax and Shingrix have been administered in the left arm. Due to biological implausibility, causality of the suspect product is assessed as not related.